Meitav Dash Investments LTD Tyme Technologies, Inc. Transaction History

Meitav Dash Investments LTD

  • $5.8 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 08, 2022
SELL
$0.6 - $1.04 $31,200 - $54,080
-52,000 Closed
0 $0
Q2 2021

Aug 05, 2021
BUY
$1.14 - $1.87 $14,819 - $24,310
13,000 Added 33.33%
52,000 $66,000
Q1 2021

May 06, 2021
BUY
$1.34 - $3.53 $52,260 - $137,670
39,000 New
39,000 $69,000

About TYME TECHNOLOGIES, INC.

TYME Quotes by TradingView
  • Ticker TYME
  • Exchange NASDAQ
  • Shares Outstandng 172,207,008
  • Description
  • Tyme Technologies, Inc., a biotechnology company, develops cancer metabolism-based therapies (CMBTs) in the United States. Its lead drug product is SM-88, a CMBT that is in a Phase II/III clinical trial to treat across 15 types of cancer, including pancreatic, prostate, breast, lung, glioma, ovarian, sarcoma, and colon. The company is also devel...
More about TYME
Track This Portfolio

Track Meitav Dash Investments LTD Portfolio

Follow Meitav Dash Investments LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Meitav Dash Investments LTD, based on Form 13F filings with the SEC.

News

Stay updated on Meitav Dash Investments LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email